COLD SPRING HARBOR, NY (GenomeWeb) — Using a CRISPR-Cas9-mediated genome-wide screen, researchers have been able to identify genes linked to skin cancer treatment resistance, according to work presented at the Biology of Genomes conference by Neville Sanjana, a postdoctoral researcher at the Broad Institute.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.